Sesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
Sesderma is recalling 20 bottles of Repaskin 30 sunscreen due to cGMP deviations. The product is distributed in Florida, Puerto Rico, Colorado, and Georgia.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II due to cGMP deviations, which typically indicates a remote risk of temporary or medically reversible adverse health consequences, aligning with the Moderate severity criteria for minor compliance issues without reported illness.
Plain-English summary
Sesderma, SL is recalling 20 bottles of Repaskin 30 Body Lotion Sunscreen gel cream, Broad Spectrum SPF 30, 6.8 fl oz (200 mL) tubes. The product is identified by Lot code 41274901 and expiration date 2/19. It is manufactured by Sesderma S.L. in Valencia, Spain.
The recall was initiated because the product does not comply with current Good Manufacturing Practice (cGMP) requirements. The agency has classified this recall as Class II.
The affected product was distributed to Florida, Puerto Rico, Colorado, and Georgia. Consumers with this specific lot should stop using the product and contact the manufacturer for instructions.
The recalled product
- Product
- Repaskin 30 (octacrylene 4%, oxybenzone 3%, octisalate 3%, octinoxate 3% Avobenzone 3%) Body Lotion Sunscreen gel cream, Broad Spectrum SPF 30, 6.8 fl oz (200 mL) tube, over the counter, Manufactured by Sesderma S.L., Valencia, Spain, NDC 63181-0012-1 UPC8 429979 415691
- Manufacturer
- Sesderma, SL
- Category
- Drug — Sunscreen
- Hazard
- Affected units
- 20
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot code 41274901
- exp 2/19.
Distribution
Part of a larger recall action
This product is one of 10 recalled by Sesderma, SL under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Sesderma, SL
See all →- ModerateSesderma Recalls Dryses Antiperspirant Solution for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Salises Acne Gel Recalled for cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Sunscreen Recalled for cGMP Non-Compliance
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 50 Sunscreen Due to cGMP Deviations
FDA (Drugs) · 2016-05-18
- ModerateSesderma Recalls Repaskin 30 Sunscreen for cGMP Deviations
FDA (Drugs) · 2016-05-18
Same hazard · cGMP deviation
See all →- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding Limits
FDA (Drugs) · 2026-07-08
- SevereCinacalcet Tablets Recalled for cGMP Deviations
FDA (Drugs) · 2026-07-08
- ModerateFentanyl Citrate Injectable Solution Recalled for cGMP Deviations
FDA (Drugs) · 2026-05-06
- ModerateIndomethacin Extended-Release Capsules recalled for cGMP deviations
FDA (Drugs) · 2025-06-11
- SevereLubricant Eye Drops Solution recalled due to sterility assurance concerns
FDA (Drugs) · 2025-05-14